Fludarabine-based Conditioning for Severe Aplastic Anemia (BMT CTN 0301)

NCT00326417 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

97

Enrollment

OTHER

Sponsor class

Conditions

Anemia, Aplastic

Interventions

DRUG: Fludarabine
DRUG: Cyclophosphamide 150mg
DRUG: Cyclophosphamide 100mg
DRUG: Cyclophosphamide 50mg

Sponsor

Medical College of Wisconsin

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]